Wockhardt Shares Soar 4% as Zaynich Shows 97% Clinical Efficacy
Shares of Wockhardt Ltd soared 4% on 13 January after the company’s drug Zaynich showed clinical efficacy of over 97% in treating critically ill patients...
Use UNICORN Signals App
By EquityPandit
